DK0663828T3 - Behandling af allergisk rhinitis og asthma ved anvendelse af (-)cetirizin - Google Patents

Behandling af allergisk rhinitis og asthma ved anvendelse af (-)cetirizin

Info

Publication number: DK0663828T3
Authority: DK; Denmark
Prior art keywords: cetirizine; treatment; allergic rhinitis; asthma; useful
Prior art date: 1992-09-24

Application number

DK93921715T

Other languages

English (en)

Inventor

Nancy M Gray

Original Assignee

Sepracor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-24

Filing date

1993-09-22

Publication date

1999-06-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25491375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0663828(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-09-22 Application filed by Sepracor Inc filed Critical Sepracor Inc

1999-06-07 Application granted granted Critical

1999-06-07 Publication of DK0663828T3 publication Critical patent/DK0663828T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Pulmonology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

DK93921715T 1992-09-24 1993-09-22 Behandling af allergisk rhinitis og asthma ved anvendelse af (-)cetirizin DK0663828T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US95117992A	1992-09-24	1992-09-24
PCT/US1993/008991 WO1994006429A1 (en)	1992-09-24	1993-09-22	Compositions for treating allergic disorders using (-) cetirizine

Publications (1)

Publication Number	Publication Date
DK0663828T3 true DK0663828T3 (da)	1999-06-07

Family

ID=25491375

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93921715T DK0663828T3 (da)	1992-09-24	1993-09-22	Behandling af allergisk rhinitis og asthma ved anvendelse af (-)cetirizin

Country Status (12)

Country	Link
US (1)	US5698558A (da)
EP (2)	EP0663828B1 (da)
JP (2)	JPH08501561A (da)
AT (1)	ATE170749T1 (da)
AU (2)	AU4932093A (da)
CA (1)	CA2145410A1 (da)
DE (2)	DE10199031I2 (da)
DK (1)	DK0663828T3 (da)
ES (1)	ES2122042T3 (da)
LU (1)	LU90898I2 (da)
NL (1)	NL300085I2 (da)
WO (1)	WO1994006429A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE170749T1 (de) *	1992-09-24	1998-09-15	Sepracor Inc	Verwendung von (-) cetirizin zur behandlung allergischer rhinitis und und asthma
EP0885611A3 (en) *	1992-09-24	1999-01-07	Sepracor, Inc.	Methods and compositions for treating allergic disorders using optically pure (+) cetirizine
GB9305282D0 (en) *	1993-03-15	1993-05-05	Ucb Sa	Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine
US6469009B1 (en)	1996-04-08	2002-10-22	Ucb, S.A.	Pharmaceutical compositions for the treatment of rhinitis
BE1011251A3 (fr) †	1997-07-03	1999-06-01	Ucb Sa	Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
US6140337A (en) *	1997-12-23	2000-10-31	Schering Corporation	Methods for the treatment of mental disorders
US6384038B1 (en) *	1998-04-14	2002-05-07	Sepracor Inc.	Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
SE9802555D0 (sv) *	1998-07-16	1998-07-16	A & Science Invest Ab	New pharmaceutical preparation and method
US6432961B1 (en)	1998-08-18	2002-08-13	Ucb S.A.	Method for preventing the onset of asthma
US7405223B2 (en)	2000-02-03	2008-07-29	Schering Corporation	Treating allergic and inflammatory conditions
AU2002256967A1 (en) *	2000-10-30	2002-09-12	Schering Corporation	Treating or reducing the risk of cardiovascular disease
US7199241B1 (en)	2001-05-29	2007-04-03	Ucb, S.A.	Process for preparing (S) and (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
US6977301B1 (en)	2001-05-29	2005-12-20	Ucb, S.A.	Process for preparing (S) and (R)—2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
AU2003272450A1 (en) *	2002-09-13	2004-04-30	C. Steven Smith	Novel composition and method for treatment of upper respiratory conditions
NZ540415A (en) *	2002-12-03	2008-06-30	Ucb Farchim Sa	Use of levocetirizine for the treatment of persistent allergic rhinitis
AU2003228011A1 (en) *	2003-05-21	2004-12-13	Wockhardt Limited	2-(2-(4-((4-chlorophenyl) phenylmethyl)-1-piperazinyl)ethoxy)acetic acid monohydrochloride as anti-allergenic compound and process for its production
GB2403655A (en) *	2003-07-11	2005-01-12	Cipla Ltd	Combined pharmaceutical product comprising a beta-2 adrenoreceptor agonist & an antihistamine for treatment of respiratory diseases such as asthma
WO2005041969A1 (en) *	2003-10-22	2005-05-12	Cipla Limited	Pharmaceutical product comprising a beta-2 adrenergic agonist and an h1-receptor antagonist
WO2005077371A1 (en) *	2004-02-12	2005-08-25	Ucb Farchim Sa	Use of levocetirizine for the preparation of a drug
EP1858866B1 (en) *	2005-03-03	2009-06-10	Ucb Farchim, S.A.	Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine
US20090082364A1 (en) *	2007-09-26	2009-03-26	Protia, Llc	Deuterium-enriched levocedtirizine
JP5291324B2 (ja) *	2007-11-01	2013-09-18	沢井製薬株式会社	口腔内崩壊錠
ATE499352T1 (de)	2007-11-21	2011-03-15	Synthon Bv	Verfahren zur herstellung von n- (diphenylmethyl)piperazinen
US7989623B2 (en)	2007-11-21	2011-08-02	Synthon Bv	Process for making n-(diphenylmethyl)piperazines
US20100145049A1 (en) *	2008-11-21	2010-06-10	Jie Zhu	Process for making n-(diphenylmethyl)piperazines
WO2010107404A1 (en)	2009-03-16	2010-09-23	Mahmut Bilgic	Stable pharmaceutical combinations
US8569273B2 (en)	2009-03-17	2013-10-29	Aciex Therapeutics, Inc.	Ophthalmic formulations of cetirizine and methods of use
WO2010107689A1 (en)	2009-03-17	2010-09-23	Aciex Therapeutics, Inc.	Ophthalmic formulations of cetirizine and methods of use
US8263581B2 (en)	2009-07-03	2012-09-11	Jdp Therapeutics, Inc.	Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en)	2009-07-03	2013-08-20	Jdp Therapeutics, Inc.	Non-sedating antihistamine injection formulations and methods of use thereof
TR201007652A2 (tr)	2010-09-20	2012-04-24	Bi̇lgi̇ç Mahmut	Sinerjik etki.
TR201009398A2 (tr)	2010-11-11	2012-05-21	Bi̇lgi̇ç Mahmut	Fiziksel özellikleri geliştirilmiş tablet formülasyonları
KR20130009553A (ko) *	2011-07-15	2013-01-23	한미약품 주식회사	몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제
KR102110304B1 (ko)	2017-06-30	2020-05-14	한미약품 주식회사	레보세티리진 및 몬테루카스트를 포함하는 안정성 및 복약순응도가 향상된 복합 츄어블정 및 그 제조방법
KR102885257B1 (ko)	2021-10-21	2025-11-12	한화제약주식회사	몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 안정성이 개선된 필름코팅 정제

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI75816C (fi) *	1981-02-06	1988-08-08	Ucb Sa	Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
GB8827390D0 (en) *	1988-11-23	1988-12-29	Ucb Sa	Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
GB8827391D0 (en) *	1988-11-23	1988-12-29	Ucb Sa	Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
DE4209649C2 (de) *	1992-03-25	1998-12-24	Schloemann Siemag Ag	Mehrstufiger hydraulischer Druck-Zylinder
EP0885611A3 (en) *	1992-09-24	1999-01-07	Sepracor, Inc.	Methods and compositions for treating allergic disorders using optically pure (+) cetirizine
ATE170749T1 (de) *	1992-09-24	1998-09-15	Sepracor Inc	Verwendung von (-) cetirizin zur behandlung allergischer rhinitis und und asthma
GB9305282D0 (en) *	1993-03-15	1993-05-05	Ucb Sa	Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine

1993
- 1993-09-22 AT AT93921715T patent/ATE170749T1/de active
- 1993-09-22 WO PCT/US1993/008991 patent/WO1994006429A1/en not_active Ceased
- 1993-09-22 EP EP93921715A patent/EP0663828B1/en not_active Expired - Lifetime
- 1993-09-22 EP EP98112640A patent/EP0950412A3/en not_active Withdrawn
- 1993-09-22 DE DE2001199031 patent/DE10199031I2/de active Active
- 1993-09-22 CA CA002145410A patent/CA2145410A1/en not_active Abandoned
- 1993-09-22 DE DE69320975T patent/DE69320975T2/de not_active Expired - Lifetime
- 1993-09-22 JP JP6508424A patent/JPH08501561A/ja active Pending
- 1993-09-22 DK DK93921715T patent/DK0663828T3/da active
- 1993-09-22 AU AU49320/93A patent/AU4932093A/en not_active Abandoned
- 1993-09-22 ES ES93921715T patent/ES2122042T3/es not_active Expired - Lifetime
1997
- 1997-01-27 US US08/789,502 patent/US5698558A/en not_active Expired - Lifetime
1998
- 1998-03-17 AU AU59343/98A patent/AU711212B2/en not_active Expired
2002
- 2002-02-08 LU LU90898C patent/LU90898I2/en unknown
- 2002-02-20 NL NL300085C patent/NL300085I2/nl unknown
2005
- 2005-10-17 JP JP2005301318A patent/JP2006036791A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
EP0950412A2 (en)	1999-10-20
NL300085I1 (nl)	2002-05-01
JPH08501561A (ja)	1996-02-20
AU4932093A (en)	1994-04-12
DE10199031I2 (de)	2004-09-23
EP0663828B1 (en)	1998-09-09
DE69320975T2 (de)	1999-05-12
NL300085I2 (nl)	2002-06-03
DE10199031I1 (de)	2001-10-04
CA2145410A1 (en)	1994-03-31
ES2122042T3 (es)	1998-12-16
US5698558A (en)	1997-12-16
AU5934398A (en)	1998-05-21
LU90898I2 (en)	2002-04-08
JP2006036791A (ja)	2006-02-09
DE69320975D1 (de)	1998-10-15
WO1994006429A1 (en)	1994-03-31
AU711212B2 (en)	1999-10-07
EP0663828A1 (en)	1995-07-26
EP0950412A3 (en)	2001-05-16
ATE170749T1 (de)	1998-09-15

Publication	Publication Date	Title
DK0663828T3 (da)	1999-06-07	Behandling af allergisk rhinitis og asthma ved anvendelse af (-)cetirizin
DK0661975T3 (da)	1999-09-27	Transdermal behandling af nældefeber ved anvendelse af optisk rent (+)-cetirizin
BG103725A (en)	2000-07-31	Nicotineamide derivatives
DK0730579T3 (da)	2001-04-17	Substituerede indoler som inhibitorer af phosphodiesterase-type-IV
AU2003273171A1 (en)	2003-12-12	Immunomodulatory compounds and methods of use thereof
ATE121389T1 (de)	1995-05-15	Ringverknüpfte analoge von stickstoffenthaltenden nichtaromatischen heterocyclen.
MX9405132A (es)	1995-01-31	Tetrahidro pirazolopiridinas biciclicas.
ES2171543T3 (es)	2002-09-16	Composiciones administrables topicamente que contienen derivados del acido 3-benzoilfenilacetico para el tratamiento de trastornos inflamatorios oftalmicos.
BRPI0411825A (pt)	2006-08-08	inibidores de p38 quinase a base de heterociclo de 5 elementos
DK0831821T3 (da)	2004-11-22	Optisk rent (-)-norcisaprid til behandling af forstyrrelser i fordöjelseskanalen
DK1049699T3 (da)	2004-07-05	Pyrazolotriaziner som CRF-antagonister
EA200100124A1 (ru)	2001-10-22	Замещенные 1,8-нафтиридин-4(1h)-оны в качестве ингибиторов фосфодиэстеразы 4
AU6995391A (en)	1991-04-18	Intermediates in the preparation of novel bicyclic esters and amides useful as specific 5-ht3 antagonists
MX9504422A (es)	1997-04-30	Tetrahidropirazolopiridinas biciclicas.
DE69030632D1 (de)	1997-06-12	Substituierte Chinolincarboxylsäure
ES2058280T3 (es)	1994-11-01	(1',5'-diaril-3-pirazolil)-n-hidroxipropanamidas 2-y 3-sustituidas farmacologicamente activas y procedimiento para su sintesis.
ES2161211T3 (es)	2001-12-01	Broncodilatadores antimuscarinicos.
NO20001343L (no)	2000-03-15	FremgangsmÕter og sammensetninger for behandling av pulmonære forstyrrelser ved anvendelse av optisk ren (S)-salmeterol
NO944339D0 (no)	1994-11-14	Melatoninderivater for anvendelse ved behandling av sövnforstyrrelser
EA200200518A1 (ru)	2002-10-31	Способ и композиция для лечения заболеваний легких
DK0548664T3 (da)	1995-09-04	2,3,3a,4,5,9b-Hexahydro- 1H-benzo (e)indol-derivater
NO951507L (no)	1995-04-20	Enantiomere cis-3-(4,6-dihydroksy-kroman-3-yl-metyl)benzosyrer
ES2138366T3 (es)	2000-01-01	Indol carbamatos como antagonistas de leucotrienos.
CN206961505U (zh)	2018-02-02	一种钢琴教学用琴谱架
FI963882A0 (fi)	1996-09-27	Bentsotiatsolijohdannaiset 5-lipoksigenaasibiosynteesin estoaineina